For food ingredient companies willing to enter the non-food market, there is over a billion dollars of market potential awaiting them. In addition to increasing the profitability of their traditional product lines, producers of ingredients can potentially expand their markets by moving their products or byproducts into the healthcare sector, where drug producers or manufacturers of some biomedical devices could incorporate them into their products.

Kalorama Information's Healthcare Opportunities for Food Ingredient Manufacturers details the sources of ancillary revenue that food manufacturer's can tap into, including the ingredients that are most sought after by healthcare companies, drivers of these ingredients, the total market potential, and the realistic market share new entrants could earn.

Among the ingredients with healthcare industry potential detailed in the report are the following:

• Purified Glycomacropeptide


• Commodity Whey Powder


• Lactoferrin


• Egg Shells


• Peanut Skin-Based


• Pectin (For Tissue Engineering)


• Pectin (Food-Grade)


• Xanthan Gum


• Soy-Based Hydrogels

CHAPTER ONE: EXECUTIVE SUMMARY
- 1.1 Re-Examining Market Opportunities
- 1.2 Looking Outside Foods for Profits
- 1.2.1 Beyond Functional Foods
- 1.3 Substantial Opportunities in Healthcare-Related Markets
- 1.4 Key Opportunities
- 1.4.1 Glycomacropeptide
- 1.4.2 Lactoferrin
- 1.4.3 Peanut Skins
- 1.4.4 Pectin
- 1.5 Market Potential Overview
- 1.6 Methodology

CHAPTER TWO: INGREDIENTS WITH HEALTHCARE APPLICATIONS
- 2.1 Overview
- 2.2 Whey Protein
- 2.2.1 Purified Fractions Are Key
- 2.2.2 Glycomacropeptide
- 2.2.3 Lactoferrin
- 2.2.4 Dairy Protein Bioactives
- 2.2.5 Serum Protein Concentrate
- 2.3 Eggshells
- 2.3.1 Source of Calcium
- 2.4 Peanut Skins
- 2.4.1 Source of Antioxidants
- 2.5 Pectin
- 2.5.1 Tissue Engineering Opportunities
- 2.6 Xanthan Gum
- 2.6.1 High Quality Xanthan Gum
- 2.7 Soybean Oil
- 2.7.1 Novel Hydrogels
- 2.8 Hurdles and Challenges

CHAPTER THREE: MARKET AND PARTNER OPPORTUNITIES
- 3.1 Glycomacropeptide
- 3.1.1 Enriching Infant Formula
- 3.1.2 Potential Market Size
- 3.1.3 Potential Partners
- 3.1.3.1 University of Wisconsin
- 3.1.3.2 Food Science Australia
- 3.1.3.3 Davisco Foods International Inc.
- 3.1.3.4 Erie Foods International
- 3.1.3.5 Farbest Brands
- 3.2 Lactoferrin
- 3.2.1 Beneficial Bioactivity
- 3.2.2 Chemopreventive Compound
- 3.2.3 Bioactive Peptides
- 3.2.4 Potential Market Size
- 3.2.5 Potential Partners
- 3.2.5.1 Applexion SAS
- 3.2.5.2 DSM
- 3.2.5.3 NutriScience Innovations LLC
- 3.2.5.4 Tatua Nutritionals
- 3.3 Serum Protein Concentrate
- 3.3.1 Membrane Filtration
- 3.3.2 Potential Market Calculations
- 3.3.3 Potential Partners
- 3.3.3.1 Cornell University
- 3.4 Egg Shells
- 3.4.1 Source of Calcium
- 3.4.2 Separation Technology
- 3.4.3 Potential Market Size
- 3.4.4 Potential Partners
- 3.4.4.1 Pennsylvania State University
- 3.4.4.2 Membrell
- 3.5 Peanut Skins
- 3.5.1 Antioxidant Source
- 3.5.2 Potential Market Size
- 3.5.3 Potential Partners
- 3.5.3.1 Virginia Tech
- 3.6 Pectin
- 3.6.1 Tissue Engineering Scaffolds and Grafts
- 3.6.2 Potential Market Size
- 3.6.3.2 Cargill Texturizing Solutions
- 3.7 Xanthan Gum
- 3.7.1 Viscosity Property
- 3.7.2 Biomedical Implants from Xanthan Gum
- 3.7.3 Potential Market Size
- 3.7.4 Potential Partners
- 3.7.4.1 Ohio State University
- 3.7.4.2 CP Kelco
- 3.7.4.3 Shanghai Honghao Chemicals Co. Ltd.
- 3.8 Thermosensitive Hydrogels
- 3.8.1 Soybean-Based Gels
- 3.8.2 Skin Grafts and Tissue Regeneration
- 3.8.3 Potential Market Size
- 3.8.4 Potential Partners
- 3.8.4.1 USDA
- 3.8.4.2 Hydromer Inc.

TABLE OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Exhibit 1-1 Healthcare Opportunities for Food Ingredient Manufacturers,
Exhibit 1-2: Potential World Tissue Engineering Market for Pectin 2007-2011
Exhibit 1-3: Potential US Antioxidant Market for Peanut Skins 2007-2011
Exhibit-1-4: Revenue Opportunities for Food Ingredient Manufacturers, 2007
CHAPTER TWO: INGREDIENTS WITH HEALTHCARE APPLICATIONS
Exhibit 2-1: Selected Bioactive Components on the Market
Exhibit 2-2: Common Hydrogel Applications
CHAPTER THREE: MARKET AND PARTNER OPPORTUNITIES
Exhibit 3-1: US Purified GMP Market Potential 2007-2011
Exhibit 3-2: US Commodity Whey Powder Market Potential for GMP 2007-2011
Exhibit 3-3: US Purified GMP Market Potential 3% Market Share 2007-2011
Exhibit 3-4: World Lactoferrin Market 2007-
Exhibit 3-5: Lactoferrin Market Potential 3% Market Share 2007-2011
Exhibit 3-6: US Market for Egg Shells for Calcium 2007-2011
Exhibit 3-7: US Market Potential for Egg Shells for Calcium 2% Market Share 2007-2011
Exhibit 3-8: Potential US for Peanut Skin-Based Antioxidants 2007-2011
Exhibit 3-9: US Peanut Skin-Based Antioxidant Market Potential 1% Market Share 2007-2011
Exhibit 3-10: World Market for Pectin for Tissue Engineering 2007-2011
Exhibit 3-11: World Market For Food-Grade Pectin 007-2011
Exhibit 3-12: World Market for Pectin for Tissue Engineering 2% Market Share 2007-2011
Exhibit 3-13: World Biomedical Device Market for Xanthan Gum 1,000 kilograms 2007-2011
Exhibit 3-14: World Skin Graft Market for Soybean-Based Hydrogels 10,000 Skin Grafts per Year 2007-2011 Revenues (in millions)